Usage of Nerve-Calming Chinese Herbal Patent Medicines in a Mental Health Center

doi:10.19803/j.1672-8629.20240456

Abstract

Abstract: Objective To investigate the usage of Chinese herbal patent medicines for calming nerves in a mental health center and to provide references for rational use of related drugs. Methods The YI-Yao Rational Drug Use Software System was used to review the prescriptions for nerve-calming Chinese herbal patent medicines from the Hospital Information System (HIS). The rationality of drug use was evaluated in terms of the days of drug use, defined daily dose (DDDs), defined daily cost (DDC) and drug utilization index (DUI). Results The top five drugs in terms of DDDs between 2018 and 2023 were Tian-meng oral liquid, Shu-gan-Jie-yu capsules, Jie-yu pills, Jian-nao capsules and Shu-mian capsules, and DUI ranged from 0.30 to 0.99. A total of 6657 improper prescriptions were screened out of 123 989 prescriptions for Chinese herbal patent medicines, so the rate of substandard prescriptions was 5.37% involving prescriptions for wrong indications (13.70%), inappropriate usage and dosage (12.36%), and inappropriate selection of drugs (2.60%). Conclusion From 2018 to 2023, the total usage and varieties of Chinese herbal patent medicines increased stably. Despite the low incidence rate of irrational use of these drugs, clinicians need to use some varieties with caution.

Key words: Chinese Herbal Patent Medicine for Calming Nerves, Defined Daily Dose (DDDs), Defined Daily Cost (DDC), Drug Utilization Index (DUI), Medication Analysis, Rational Drug Use, Mental Health Center

CLC Number:

R971
R994.11

ZHOU Kun, MA Liang, LI Zhaofeng, CAO Bing, GU Hongwei, LIU Qian. Usage of Nerve-Calming Chinese Herbal Patent Medicines in a Mental Health Center[J]. Chinese Journal of Pharmacovigilance, 2025, 22(2): 211-216.

Add to citation manager EndNote|Ris|BibTeX

URL: https://zgywjj.magtechjournal.com/EN/10.19803/j.1672-8629.20240456

https://zgywjj.magtechjournal.com/EN/Y2025/V22/I2/211

References

[1] LUO YN, PANG LH, GUO C, et al.Prevalence and Development of Mental Disability in Mega Cities[J]. Chinese Journal of Disease Control & Prevention(中华疾病控制杂志), 2021, 25(8): 981-986.
[2] WU XT, LUO BD.Analysis of the Effect of Drug Therapy Combined with Cognitive Behavior Intervention on Patients with Sleep Disorders and Depression[J]. Journal of North Sichuan Medical College(川北医学院学报), 2022, 37(5): 675-678.
[3] HUANG DX, LI R, CHEN Y, et al.Clinical Observation of 92 Patients with Insomnia Treated by Low Frequency Electronic Pulse Sleep Apparatus[J]. Modern Hospitals(现代医院), 2022, 22(7): 1146-1148.
[4] WU CH, LIU M, HUANG HY.Analysis of the Effectiveness of Systemic Sleep Care Intervention in Patients with Schizophrenia with Sleep Disorders[J]. World Journal of Sleep Medicine(世界睡眠医学杂志), 2023, 10(9): 2222-2224.
[5] ZHOU XY, GUO LM, CHEN N.Research Progress of Repetitive Transcranial Magnetic Stimulation in the Treatment of Sleep Disorders in Neurological and Psychiatric Diseases[J]. Chinese Journal of Practical Neurological Diseases(中国实用神经疾病杂志), 2019, 27(9): 1173-1178.
[6] XU AH, JIANG YQ, JIE Y, et al.Correlation Between Types of Traditional Chinese Medicine Constitutions Differentiation and Psychiatric Symptom in Schizophrenic Patients[J]. China Journal of Health Psychology(中国健康心理学杂志), 2022, 30(7): 980-984.
[7] ZHENG Y, CONG WD, LIN L, et al.Effect of Lorazepam on Sleep and Mental Symptoms in Patients with Schizophrenia and Sleep Disorders[J]. World Journal of Sleep Medicine(世界睡眠医学杂志), 2024, 11(6): 1400-1402.
[8] SHANG ZJ, ZHANG Z, LI HW.Clinical Analysis of Drug Therapy for Chronic Insomnia[J]. China Journal of Health Psychology(中国健康心理学杂志), 2021, 29(2): 197-200.
[9] LIU Q, GUANG S, CHEN YF, et al.Research Progress on Treatment of Intractable Insomnia with Traditional Chinese and Western Medicine[J]. Journal of Basic Chinese Medicine, 2021, 27(10): 1670-1674.
[10] CHENG GH,QIAN JN, DENG YJ.Efficacy of Mirtazapine Combined with Dexzopiclone in the Treatment of Post-Ischemic Stroke Depression with Insomnia[J]. World Journal of Sleep Medicine(世界睡眠医学杂志), 2022, 9(12): 2245-2248.
[11] CHEN YL.Benzodiazepine and Related Drug Use and Risk of Dementia: a System Meta-Analysis[D]. Dalian: Dalian Medical University, 2021.
[12] PENG LD, MORFORD K, LEVANDER XAA.Benzodiazepines and Related Sedatives[J]. Medical Clinics of North America, 2022, 106(1) :113-129.
[13] KINI K, RAJU S.Clinical Challenges in Managing Zolpidem Use Disorder[J]. Annals of Indian Psychiatry, 2021, 5(2): 173-174.
[14] SEMIH G.Generalized Seizure Developing in the Course of the Administration of Zolpidem: a Case Report[J]. Psychiatry and Clinical Psychopharmacology, 2021, 18(3): 197-200.
[15] ZHANG S, TANG BY.Adverse Reaction Risk Signal of Insomnia Related to Mirtazapine Based on FAERS Database[J]. Bachu Medical Journal(巴楚医学), 2021, 4(4): 85-90.
[16] LI MJ, YE TY, QI DM, et al.Research Status of Clinical Trials of Drugs and Interventions for Anxiety disorders[J]. Chinese General Practice(中国全科医学), 2021, 24(11): 1418-1425.
[17] JIN GE, FENG ZH, ZHAO YB, et al.Retrospective“Real World”Study of Primary Insomnia Traditional Chinese Medicine Syndrome Treatment Rules and High-Frequency Herbs Mechanism[J]. Chinese Journal of Hospital Pharmacy(中国医院药学杂志), 2022, 42(5): 549-554.
[18] JIANG JX, LI N, ZHAO LR, et al.Advances in Research on Mechanism of Chinese Medicine for Preventing and Treating Insomnia[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2022, 24(1): 178-181.
[19] HU DL.Review and Analysis of Prescription of Patent Chinese Medicine in Pediatric Outpatient Department of Hospital from 2016 to 2018[J]. Guizhou Medicine(贵州医药), 2019, 45(3): 450-451.
[20] ZHANG Y.Analysis of Rational Drug Use of Proprietary Chinese Medicines in Pediatric Outpatient Department[J]. Journal of Clinical Rational Drug Use(临床合理用药杂志), 2019, 14(15): 142-144.
[21] National Pharmacopoeia Committee.Pharmacopoeia of the People’s Republic of China 2020 Edition (Part I) - Clinical Medication Instructions: Chinese Herbal Formula Preparation Volume(中华人民共和国药典临床用药须知-中药成方制剂卷)[M]. Beijing: China Medical Science and Technology Press, 2020: 2-23
[22] SONG MX, YANG M.New National Traditional Chinese Patent Medicines and Simple Preparations(新编国家中成药)[M]. Beijing: People's Medical Publishing Houses, 2020.
[23] LI YW, CHANG XH, LIU S, et al.Analysis of the Use of Proprietary Chinese Medicines for the Treatment of Cardiovascular and Cerebrovascular Diseases in a Hospital in 2019[J]. Chinese Traditional Patent Medicine(中成药), 2022, 44(2): 672-676.
[24] LIU C.Analysis on the Use of Chinese Patent Drugs for Anti-Tumor in Liaoning Cancer Hospital and Institute from 2017 to 2019[J]. Journal of Liaoning University of Traditional Chinese Medicine(辽宁中医药大学学报), 2021, 23(5): 203-206.